Skip to content

Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD)

Phénotype Lymphocytaire Des Ichtyoses congénitales Autosomiques récessives mutées NIPAL4 (Nipal4-nEDD)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07477769
Acronym
NIPALYMPHO
Enrollment
10
Registered
2026-03-17
Start date
2026-04-01
Completion date
2027-10-01
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ichthyosis, Lamellar, Sezary Syndrome

Keywords

nEDD, NIPA like domain containing4 protein, human, Sezary Syndrome, Lymphocyte Immunophenotyping

Brief summary

Autosomal recessive congenital ichthyoses (ARCI) are monogenic diseases of cornification that correspond to a diffuse abnormality (affecting the entire integument) of epidermal differentiation and therefore of the skin barrier. They manifest as abnormal desquamation (scaling) associated with varying degrees of inflammation (erythema). Around ten genes are currently implicated in ARCI. Nipal 4 is one of these genes, and mutations in it are found in around 1/10 of genotyped ARCI patients. As part of this follow-up, three Nipal4 ARCI (Nipal4-nEDD) patients followed by the dermatology department of Saint-Louis hospital (Paris) were diagnosed with Sezary syndrome, a rare and serious cutaneous lymphoma (incidence 1/10,000,000), in adulthood (aged 30, 46, and 82). This lymphoma was diagnosed following a change in skin phenotype with worsening erythema, pruritus, and hyperkeratosis. The occurrence of two very rare diseases ( Nipal4-nEDD) and Sezary syndrome) in three patients raises the question of a non-coincidental association. The diagnosis of Sézary syndrome is based on a specific pathological circulating lymphocyte phenotype and is confirmed by skin histology. There is currently no obvious pathophysiological explanation for the concomitant occurrence of these two skin diseases. The blood lymphocyte phenotype of Nipal 4-nEDD patients without Sezary syndrome (SS) is unknown. A first step in investigating the mechanisms that could explain such an association would be to document this baseline lymphocyte phenotype in the Nipal 4-nEDD population without known SS.

Interventions

OTHERblood sampling

Supplementary blood collection performed during routine venipuncture

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (\> 18 years old) * ARCI-type ichthyosis with NIPAL4 mutation (Nipal4-nEDD)

Exclusion criteria

* Ichthyosis that has not been genotyped or with mutations in different genes * Patients with concomitant inflammatory, infectious, or hematological conditions * Individuals subject to legal protection measures or deprived of their liberty by judicial or administrative decision * Individuals under guardianship/curatorship * Opposition to the research

Design outcomes

Primary

MeasureTime frameDescription
Proportion of blood lymphocyte phenotype18 monthsDescription of the complete blood lymphocyte phenotype by immunophenotyping

Contacts

CONTACTEmmanuelle Bourrat, MD
emmanuelle.bourrat@aphp.fr01 42 49 90 90
CONTACTJérôme Lambert, MD PhD
jerome.lambert@u-paris.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026